Dextran 2000 - MW: 1,500,000 to 3,500,000
CAS: 9004-54-0
Rif. 3D-OD156913
1g | Fuori produzione | ||
2g | Fuori produzione | ||
5g | Fuori produzione | ||
10g | Fuori produzione | ||
25g | Fuori produzione | ||
50g | Fuori produzione | ||
100g | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
- Cdc-H
- Dextran11
- Dextran2
- Dextran5
- Dextranen
- DextrangradeA,B,C
- Dextrano
- Dextrans
- Dextraven
- Eudextran
- Vedi altri sinonimi
- Ex-pandex
- Expandex
- Gentran
- Gentran3
- Hemodex
- Hyscon
- Hyskon
- Infucoll
- Intrader
- Intradex
- LMD
- LVD
- Lmwd
- Macrodex
- Macrose
- Mucrose
- Onkotin
- Plasmafusin
- Plasmodex
- Plavolex
- Polyglucin
- Polyglusol
- Promit
- R-gel
- Rheodextran
- Rheoisodex
- Rheomacrodex
- Rheopolyglucin
- Rheopolyglucine
- Rheorondex
- Rheotran
- Rondex
- Ultradex
- α-Dextran
- Dextran 70
- Dextran 40
- Glucose polymer
- Dextran 45
- Dextran
Dextran 2000 is a high molecular weight biocompatible polymer with transport properties. It is used in a variety of medical applications, such as red blood cell transfusions and the prevention of post-surgical adhesions. Dextran 2000 has been shown to be a safe and effective means of preventing hemolysis during red blood cell transfusion. This agent binds to amine groups on the surface of erythrocytes, which prevents complement activation and subsequent lysis. Additionally, dextran 2000 has been shown to exhibit low cytotoxicity against neuronal cells in vitro.